NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceutical’

9 April 2015

Venture capital-backed protein biologics company aTyr Pharma files for IPO

download (4) Rare disease specialist aTyr Pharma, whose venture capital backers include Alta Partners, Cardinal Partners and Domain Associates, has filed for an IPO.

16 March 2015

TPG-backed Par Pharmaceutical registers for IPO

clinic health drugs pharma Generic drugmaker Par Pharmaceutical Holdings, which is owned by TPG has filed for an initial public offering and stated its nominal target as $100m.

13 March 2015

NEA, Hatteras reup in PhaseBio through $40m Series C round

heart_lrg New Enterprise Associates and Hatteras Venture Partners have renewed their commitment to PhaseBio Pharmaceuticals through a $40m Series C round.

17 February 2015

Versant, Frazier drive $30m Series B for US company Laguna Pharmaceuticals

BPL monitor Healthcare investors Versant Ventures and Frazier Healthcare have led a $30m financing round for cardia arrhythmia-focused Laguna Pharmaceuticals.

27 January 2015

China’s Legend Capital heads up $100m Series C for Innovent Biologics

pharmaceutical 12_sq Beijing-based venture capital firm Legend Capital has led a $100m Series C funding round for Chinese biopharmaceutical company Innovent Biologics.

7 January 2015

NeoMed co-leads $19.7m Series D for drug developer Genkyotex

pills-1111307-m European venture capital firm NeoMed Management has led a CHF20m ($19.7m) financing round for Genkyotex, a company developing drugs to treat diseases of the kidney, liver, lung and skin.

2 January 2015

NEA, KPCB back $28.5m 3-V Biosciences Series D

cancer juno Venture capital firms including New Enterprise Associates and Kleiner Perkins Caufield & Byers have backed a $28.5m Series D financing round for pharmaceutical business 3-V Biosciences.

5 December 2014

GSK abandons $3bn-plus plan to sell older drugs portfolio

pills-1111307-m Pharmaceutical giant GlaxoSmithKline has decided not to sell a portfolio of older drugs marketed in North America and Europe, despite strong interest from private equity firms and offers upwards of $3bn.

27 November 2014

Idinvest seals 7.6x return exiting Prosensa through $680m buyout

Prosensa Idinvest Partners has made a 7.6-times return by exiting its stake in Dutch biotechnology business Prosensa in a deal which values the business at $680m.

19 November 2014

Black Toro snaps up Spain’s Antibioticos

pills-755958-m Black Toro Capital has acquired Spanish pharmaceutical company Antibioticos.

Page 1 of 2012345...1020...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015